Top licensing prospects from the University of Wisconsin-Madison
Gene Editing to Treat Pompe Disease and Other Autosomal Recessive Disorders
UW-Madison researchers have developed a complexed CRISPR-Cas gene editing approach for treating Pompe disease.
Methods to Screen Antifungal Compounds and Treat Fungal Diseases by Inhibiting Spore Germination
Four FDA-approved compounds and 108 druggable compounds with germination-inhibiting properties and high potential for further development into effective antifungal therapeutics have been identified using this approach.
Generating LPS-Specific Exosome-Educated Macrophages
This strategy can be used to produce therapeutic macrophages that offer a potential therapy for radiation damage.
Hepatocytes and Hematopoietic Progenitors from Human Embryonic Stem Cells
This system involves differentiating embryonic stem cells in co-culture with mouse embryonic fibroblasts under specific conditions to give rise to both hepatic and hematopoietic lineages.
Meet Andy DeTienne!
In the News